Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$318.86
+104.8%
Analyst Price Target
$193.80
+24.4%

Stock Statistics — BDX

Becton, Dickinson and Company (BDX) has a market capitalization of $56.42B and trades at $155.73. The 52-week range is 127.58648-187.35.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 26.7, Earnings Per Share (EPS) of $5.84, annual revenue of $21.84B.

The stock has a beta of 0.35, a last dividend of $3.5107, operates in the Healthcare sector.

Trading Data
Current Price$155.73
52-Week Range127.58648-187.35
Volume2.7M
Avg Volume (30D)2.84M
Market Cap$56.42B
Beta (1Y)0.35
Last Dividend$3.5107
Company
IPO Date1973-02-21
Employees70,000
CEOThomas E. Polen Jr.
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS0758871091
CUSIP075887109
Income (Latest Year)
Revenue$21.84B
Gross Profit$9.92B
EBITDA$4.96B
Operating Income$2.58B
Net Income$1.68B
EPS$5.84
EPS Diluted$5.83
Shares Outstanding$286.61M
Balance Sheet (Latest Year)
Total Assets$55.33B
Current Assets$9.26B
Cash & ST Investments$859M
Total Liabilities$29.94B
Total Debt$19.18B
Net Debt$18.33B
Total Equity$25.39B
Debt / Equity0.76
Valuation Ratios
P/E Ratio26.7
P/S Ratio2.58
P/B Ratio2.22
EV/EBITDA (approx)11.4
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message